Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Astria Therapeutics Inc (ATXS)

Astria Therapeutics Inc (ATXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Halper Sadeh LLC Encourages CSGS, JHG, CWAN, ATXS Shareholders to Contact the Firm to Discuss Their Rights PR Newswire - Thu Jan 8, 11:50AM CST

Shareholders should contact the firm as there may be limited time to enforce your rights.  

ATXS : 12.72 (-1.24%)
CSGS : 79.49 (-0.03%)
JHG : 47.95 (+0.40%)
CWAN : 24.09 (-0.17%)
Astria Therapeutics Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Astria Therapeutics, Inc. - ATXS PR Newswire - Wed Jan 7, 4:12PM CST

NEW YORK and NEW ORLEANS , Jan. 7, 2026 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti , LLC ("KSF") are investigating the...

ATXS : 12.72 (-1.24%)
BCRX : 7.09 (-4.19%)
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--ATXS, MBCN, FMNB, and SEMR PR Newswire - Fri Dec 19, 2025

NEW YORK , Dec. 19, 2025 /PRNewswire/ -- Class Action Attorney Juan Monteverde  with Monteverde & Associates PC  (the "M&A Class Action Firm"), has recovered millions of dollars...

ATXS : 12.72 (-1.24%)
SEMR : 11.89 (unch)
MBCN : 34.26 (-0.58%)
FMNB : 13.25 (-0.60%)
Halper Sadeh LLC Encourages RNA, TCBX, ATXS, FSUN Shareholders to Contact the Firm to Discuss Their Rights PR Newswire - Mon Dec 1, 2025

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.  

ATXS : 12.72 (-1.24%)
TCBX : 37.94 (-0.65%)
RNA : 72.35 (-0.03%)
FSUN : 38.68 (-0.64%)
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--TCBX, RNA, ATXS, and FSUN PR Newswire - Mon Dec 1, 2025

NEW YORK , Dec. 1, 2025 /PRNewswire/ -- Class Action Attorney Juan Monteverde  with Monteverde & Associates PC  (the "M&A Class Action Firm"), has recovered millions of dollars for...

ATXS : 12.72 (-1.24%)
TCBX : 37.94 (-0.65%)
RNA : 72.35 (-0.03%)
FSUN : 38.68 (-0.64%)
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Mergers-SPNS, PCH, ATXS, and RYN PR Newswire - Fri Nov 21, 2025

NEW YORK , Nov. 21, 2025 /PRNewswire/ -- Class Action Attorney Juan Monteverde  with Monteverde & Associates PC  (the "M&A Class Action Firm"), has recovered millions of dollars...

ATXS : 12.72 (-1.24%)
SPNS : 43.45 (+0.02%)
PCH : 42.83 (-0.67%)
RYN : 23.19 (-1.11%)
Halper Sadeh LLC Encourages HSII, MRUS, ATXS Shareholders to Contact the Firm to Discuss Their Rights PR Newswire - Wed Nov 12, 2025

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.  

ATXS : 12.72 (-1.24%)
MRUS : 90.00 (-7.14%)
HSII : 59.01 (+0.07%)
Astria Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Corporate Update Business Wire - Wed Nov 12, 2025

-- BioCryst’s Acquisition of Astria Expected to Close in the First Quarter of 2026 -- -- Phase 3 ALPHA-ORBIT Trial for Navenibart is Progressing as Planned...

ATXS : 12.72 (-1.24%)
BCRX : 7.09 (-4.19%)
Astria Therapeutics Announces Final Positive Results from All Enrolled HAE Patients in the ALPHA-STAR Phase 1b/2 Trial of Navenibart Business Wire - Thu Nov 6, 2025

-- Final ALPHA-STAR Phase 1b/2 Results from the Full-Enrollment Population (n=29) Remain Highly Consistent with Prior Results from the Target-Enrollment Population (n=16), Demonstrating Strong Efficacy,...

ATXS : 12.72 (-1.24%)
Astria Therapeutics to Present at Upcoming American College of Allergy, Asthma, and Immunology Annual Scientific Meeting Business Wire - Fri Oct 31, 2025

Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced that it will present final...

ATXS : 12.72 (-1.24%)

Barchart Exclusives

Watch This Overlooked Stock Chart as the Secular Commodity Bull Run Heats Up Barchart - Mon Jan 12, 3:48PM CST
Our top chart expert explains why BALL stock is on his radar, and the key levels in play now. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot